Publication: 228

Consolidation Therapy With Subcutaneous Alemtuzumab After Fludarabine and Rituximab Induction Therapy for Previously Untreated Chronic Lymphocytic Leukemia: Final Analysis of CALGB 10101
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 28 (29) 4500-4506
Year:
2010
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
462   700  
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, U10 CA031946, U10 CA033601, R21 CA101332, R21CA101332, CA31946  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
CALGB-10101
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Hema5, Hema6, Hema7, Original Reports, Hematologic Malignancies